Duvelisib (IPI-145, INK1197) , ≥98% , 1201438-56-3
CAS NO.:1201438-56-3
Empirical Formula: C22H17ClN6O
Molecular Weight: 416.86
MDL number: MFCD15144635
EINECS: 200-256-5
| Pack Size | Price | Stock | Quantity | 
| 5MG | RMB319.20 | In Stock | 
                                                 | 
                                        
| 10mg | RMB439.20 | In Stock | 
                                                 | 
                                        
| 25MG | RMB799.20 | In Stock | 
                                                 | 
                                        
| 50mg | RMB1279.20 | In Stock | 
                                                 | 
                                        
| 100MG | RMB1898.40 | In Stock | 
                                                 | 
                                        
| 1G | RMB7180.80 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
PRODUCT Properties
| Melting point: | 205-206o C | 
                                    
| Boiling point: | 757.8±60.0 °C(Predicted) | 
                                    
| Density | 1.474±0.06 g/cm3(Predicted) | 
                                    
| storage temp. | -20°C | 
                                    
| solubility | Soluble in DMSO (up to at least 25 mg/ml) | 
                                    
| form | White solid. | 
                                    
| pka | 10.05±0.10(Predicted) | 
                                    
| color | White | 
                                    
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. | 
                                    
| InChI | InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1 | 
                                    
| InChIKey | SJVQHLPISAIATJ-ZDUSSCGKSA-N | 
                                    
| SMILES | C1(=O)C2=C(C=CC=C2Cl)C=C([C@@H](NC2=C3C(=NC=N2)NC=N3)C)N1C1=CC=CC=C1 | 
                                    
Description and Uses
Duvelisib (1201438-56-3) is a potent and selective (IC50’s: PI3Kα = 1602nM, PI3Kβ = 85nM, PI3Kδ= 2.5nM, PI3Kγ = 27nM) dual PI3Kδ/γ inhibitor.1 It inhibits B and T cell proliferation, blocks neutrophil migration, and inhibits basophil activation. Duvelisib antagonizes B-cell receptor cross-linking activated pro-survival signals in primary chronic lymphocytic leukemia cells.2?Duvelisib also shows preclinical/clinical activity against other hematologic malignancies such as Non-Hodgkins lymphoma, T-cell lymphoma, and others.3,4?Useful clinical agent for the treatment of various blood cancers. Low-dose treatment of T-cell-inflamed tumor models of head and neck cancers with Duvelisib enhanced responses to PD-L1 blockade via suppression of myeloid-derived suppressor cells.5?Higher doses reversed the effect due to suppression of tumor-infiltrating T lymphocytes
IPI 145 is an 1,2-dihydroisoquinolin-1(2H)-one derivative and has been developed as a modulator of PI3 kinase.
Safety
| Symbol(GHS) | ![]() GHS08  | 
                                    
| Signal word | Danger | 
| Hazard statements | H360 | 
| Precautionary statements | P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501 | 







